Drug recall
Enoxaparin Sodium Injection, USP, 40 mg/0.4 mL, Single-Dose Syringes with Automatic Safety Device, For…
FDA recall event 89033 · Class I · Sandoz Inc
Key facts
| Event ID | 89033 |
|---|---|
| Recall numbers | D-0286-2022 |
| Recalling firm | Sandoz Inc |
| Product type | Drugs |
| Products | Enoxaparin Sodium Injection, USP, 40 mg/0.4 mL, Single-Dose Syringes with Automatic Safety Device, For Subcutaneous Injection, Rx Only; 0.4 mL Syringes, Manufactured for Sandoz Inc., Princeton, NJ… |
| Classification | Class I |
| Status | Completed |
| Voluntary or mandated | Voluntary: Firm Initiated |
| Reason for recall | Temperature Abuse; temperature excursion during shipping |
| Initiation date | Nov 17, 2021 |
| Report date | Dec 8, 2021 |
| City | Princeton |
| State | NJ |
| Country | United States |
| FEI number | 3011552892 |
At a glance
- 1–9 Products in this recall
- None FDA inspections of this firm (FEI)
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About FDA drug and product recalls
FDA enforcement reports list recalls of drugs, biologics, foods and other FDA-regulated products, classified by the potential health hazard.
Source: U.S. Food and Drug Administration (FDA), Enforcement Reports · Source date: